19 June 2013
Keywords: genmab/gsk, humax, cd20, deal, gets, ftc, ok
Article | 12 February 2007
Danish biotechnology company Genmab AS says that the worldwide agreement with UK-based drug major GlaxoSmithKline, which is focused on the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 February 2007
18 June 2013
© 2013 thepharmaletter.com